Expired Canadian patentCanada
Modified factor viii
CA 2400295 C · Owner: Emory University · Inventors: Lollar, John S.
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to a modified B-domainless form of porcine factor VIII to a DNA encoding the same, and to the use thereof for treatment of hemophilia.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 16, 2001 and granted January 10, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended February 16, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 16, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledFebruary 16, 2001
GrantedJanuary 10, 2012
Term endedFebruary 16, 2021
Patent numberCA 2400295 C
Classification (IPC)C12N15/12 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.